Radboud University Medical Center: Hepatitis C trials

The registry lists 11 Hepatitis C studies with Radboud University Medical Center as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 1 6Phase 2 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• 'Fibrosis in the Lost Hepatitis C Population - Track, Trace and Treat'CompletedNCT03088917Results posted
• Evaluating the Chain of Addiction Care (CAC)Status unknownNCT05401136
• Hepatitis C Elimination in the NetherlandsStatus unknownNCT04208035
• Bioequivalence Study of Crushed Elbasvir/Grazoprevir Compared to the Whole TabletCompletedNCT03817619Phase 1
• Influence of Cola on the Absorption of the HCV Agent Velpatasvir in Combination With PPI Omeprazole.CompletedNCT03513393Phase 1
• A Drug-drug Interaction Study Between Daclatasvir and Atazanavir/Ritonavir or Atazanavir/CobicistatCompletedNCT02565888Phase 1
• A Drug-drug Interaction Study Between Daclatasvir and MetforminCompletedNCT02565862Phase 1
• Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA RegimensCompletedNCT02505243
• Interaction Between Paroxetine and TelaprevirTerminatedNCT01841502Phase 2
• Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO)CompletedNCT01470690Phase 1
• Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor RaltegravirCompletedNCT01288417Phase 1